-+ 0.00%
-+ 0.00%
-+ 0.00%

Valerio Therapeutics targets Aug. 21 signing for Etherna deal talks

PUBT·08/17/2026 06:00:23
Listen to the news
Valerio Therapeutics targets Aug. 21 signing for Etherna deal talks
  • Valerio Therapeutics is advancing plans to buy 100% of Etherna Immunotherapies, following a binding offer based on a EUR 30 million enterprise value.
  • The parties extended talks to complete definitive agreements, targeting signing by Aug. 21, 2026.
  • Foreign direct investment clearance required for the deal has been obtained.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Valerio Therapeutics SA published the original content used to generate this news brief via Business Wire (Ref. ID: 20260816266987) on August 17, 2026, and is solely responsible for the information contained therein.